Metraipolis › archive › dc_4ce8e4bc0ef6
Interferon-primed immune landscapes predict immune-related adverse events during immune checkpoint inhibitor therapy — Europe PMC PMID:42181691
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42181691
- DOI
- 10.3389/fcell.2026.1798845
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-17T11:43:06.847Z
- SHA-256 of the archived text
f808b898cd75166a24ab182f7f0918e451027aa373a082288d83ce555645818e- Stable URL of this page
https://metraipolis.com/documento/dc_4ce8e4bc0ef6
How to cite
Interferon-primed immune landscapes predict immune-related adverse events during immune checkpoint inhibitor therapy — Europe PMC PMID:42181691 — Europe PMC (en), https://europepmc.org/article/MED/42181691 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4ce8e4bc0ef6 (Metraipolis archive dc_4ce8e4bc0ef6, sha256 f808b898cd75166a24ab182f7f0918e451027aa373a082288d83ce555645818e)
BibTeX
@misc{dc4ce8e4bc0ef6,
title = {Interferon-primed immune landscapes predict immune-related adverse events during immune checkpoint inhibitor therapy — Europe PMC PMID:42181691},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42181691},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4ce8e4bc0ef6; sha256 f808b898cd75166a24ab182f7f0918e451027aa373a082288d83ce555645818e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42181691. Agents can read the archived copy with the MCP tool read_document.